Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.

Abstract:

:Patients who are diagnosed with osteosarcoma (OS) today receive the same therapy that patients have received over the last 4 decades. Extensive efforts to identify more effective or less toxic regimens have proved disappointing. As we enter a postgenomic era in which we now recognize OS not as a cancer of mutations but as one defined by p53 loss, chromosomal complexity, copy number alteration, and profound heterogeneity, emerging threads of discovery leave many hopeful that an improving understanding of biology will drive discoveries that improve clinical care. Under the organization of the Bone Tumor Biology Committee of the Children's Oncology Group, a team of clinicians and scientists sought to define the state of the science and to identify questions that, if answered, have the greatest potential to drive fundamental clinical advances. Having discussed these questions in a series of meetings, each led by invited experts, we distilled these conversations into a series of seven Provocative Questions. These include questions about the molecular events that trigger oncogenesis, the genomic and epigenomic drivers of disease, the biology of lung metastasis, research models that best predict clinical outcomes, and processes for translating findings into clinical trials. Here, we briefly present each Provocative Question, review the current scientific evidence, note the immediate opportunities, and speculate on the impact that answered questions might have on the field. We do so with an intent to provide a framework around which investigators can build programs and collaborations to tackle the hardest problems and to establish research priorities for those developing policies and providing funding.

journal_name

Cancer

journal_title

Cancer

authors

Roberts RD,Lizardo MM,Reed DR,Hingorani P,Glover J,Allen-Rhoades W,Fan T,Khanna C,Sweet-Cordero EA,Cash T,Bishop MW,Hegde M,Sertil AR,Koelsche C,Mirabello L,Malkin D,Sorensen PH,Meltzer PS,Janeway KA,Gorlick R,Cro

doi

10.1002/cncr.32351

subject

Has Abstract

pub_date

2019-10-15 00:00:00

pages

3514-3525

issue

20

eissn

0008-543X

issn

1097-0142

journal_volume

125

pub_type

杂志文章,评审

相关文献

CANCER文献大全
  • Associations between smoking status and stage of colorectal cancer at diagnosis in Massachusetts between 1982 and 1987.

    abstract::To examine the relationship between smoking and stage of colorectal cancer at diagnosis, data on 2788 current smokers and 6313 nonsmokers with known stage at diagnosis were obtained from the Massachusetts Cancer Registry. The stage at diagnosis was treated as a polytomous response variable in a logit-type, log-linear ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890915)64:6<1372::aid-cncr2820

    authors: Longnecker MP,Clapp RW,Sheahan K

    更新日期:1989-09-15 00:00:00

  • Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.

    abstract:BACKGROUND:The optimal weekly oral dose of sirolimus and intravenous nanoparticle albumin-bound paclitaxel (nab-paclitaxel) were evaluated. METHODS:A phase 1b study was performed to evaluate escalating doses of oral sirolimus (5-60 mg) on days 2, 9, and 16 with intravenous nab-paclitaxel (100 mg/m(2) ) on days 1, 8, a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29254

    authors: Abu-Khalaf MM,Baumgart MA,Gettinger SN,Doddamane I,Tuck DP,Hou S,Chen N,Sullivan C,Lezon-Geyda K,Zelterman D,Hatzis C,Deshpande H,Digiovanna MP,Azodi M,Schwartz PE,Harris LN

    更新日期:2015-06-01 00:00:00

  • Treatment outcome in older patients with childhood acute myeloid leukemia.

    abstract:BACKGROUND:Older age has historically been an adverse prognostic factor in pediatric acute myeloid leukemia (AML). To the authors' knowledge, the impact of age relative to that of other prognostic factors on the outcome of patients treated in recent trials is unknown. METHODS:Clinical outcome and causes of treatment f...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.27659

    authors: Rubnitz JE,Pounds S,Cao X,Jenkins L,Dahl G,Bowman WP,Taub JW,Pui CH,Ribeiro RC,Campana D,Inaba H

    更新日期:2012-12-15 00:00:00

  • Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.

    abstract:BACKGROUND:Patients with superficial (mucosal or submucosal) esophageal carcinoma (SEC) have significantly better survival rates than patients with advanced carcinoma. Some patients with advanced esophageal carcinoma have been reported to test positive for serum p53 antibodies (Abs). Because very few patients with supe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Shimada H,Takeda A,Arima M,Okazumi S,Matsubara H,Nabeya Y,Funami Y,Hayashi H,Gunji Y,Suzuki T,Kobayashi S,Ochiai T

    更新日期:2000-10-15 00:00:00

  • Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.

    abstract:BACKGROUND:Women treated with tamoxifen for breast cancer are at increased risk of endometrial cancer. This study examines the experience at Roswell Park Cancer Institute (RPCI) with women diagnosed with both endometrial carcinoma (EC) and breast carcinoma (BC) to determine the risk and stage of endometrial carcinoma a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960515)77:10<2058::AID-C

    authors: Cuenca RE,Giachino J,Arredondo MA,Hempling R,Edge SB

    更新日期:1996-05-15 00:00:00

  • Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma.

    abstract:BACKGROUND:Multiple cell-signaling ligands and receptors-including vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), endothelial growth factor (EGF), v-akt murine thymoma viral oncogene homolog (AKT), platelet-derived growth factor (PDGF), mitogen-activated protein kinase (MAPK), and 70-kilod...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24562

    authors: Abdeen A,Chou AJ,Healey JH,Khanna C,Osborne TS,Hewitt SM,Kim M,Wang D,Moody K,Gorlick R

    更新日期:2009-11-15 00:00:00

  • Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma.

    abstract::Cis-diamminedichloride platinum II (DDP) was administered to eight patients with epidermoid carcinoma of the penis. Three of six adequately treated patients had an objective response: one patient achieved complete remission of 7 months duration and 2 patients had partial remissions of 8 and 2 months, respectively. DDP...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197911)44:5<1563::aid-cncr282044

    authors: Sklaroff RB,Yagoda A

    更新日期:1979-11-01 00:00:00

  • Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?

    abstract:BACKGROUND:For many childhood cancers, survival is lower among non-Hispanic blacks and Hispanics in comparison with non-Hispanic whites, and this may be attributed to underlying socioeconomic factors. However, prior childhood cancer survival studies have not formally tested for mediation by socioeconomic status (SES). ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31560

    authors: Kehm RD,Spector LG,Poynter JN,Vock DM,Altekruse SF,Osypuk TL

    更新日期:2018-10-15 00:00:00

  • Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.

    abstract:BACKGROUND:The Akt/mammalian target of the rapamycin (mTOR) signaling pathway represents a promising target for cancer therapy. The phosphorylation status of Akt and of mTOR's phosphorylation target eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) is often used to assess the activity of Akt and mTOR signaling...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23456

    authors: Akcakanat A,Sahin A,Shaye AN,Velasco MA,Meric-Bernstam F

    更新日期:2008-06-01 00:00:00

  • Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.

    abstract:BACKGROUND:National Cancer Institute (NCI)/National Comprehensive Cancer Network (NCCN)-designated cancer centers (CCs) offer patients state-of-the-art treatment, but their impact on multiple myeloma (MM) patient outcomes has not been evaluated. METHODS:Adult MM patients diagnosed between 1973 and 2011 were identified...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29771

    authors: Ailawadhi S,Advani P,Yang D,Ghosh R,Swaika A,Roy V,Foran J,Colon-Otero G,Chanan-Khan A

    更新日期:2016-02-15 00:00:00

  • Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.

    abstract::A bolus intravenous dose of 5-fluorouracil of 600 mg/M2 was added exactly 1 hour after methotrexate administration in an established combination program including bleomycin and cisplatin for advanced squamous cell cancer of the head and neck. Results were no better than those observed previously with the three drugs, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860215)57:4<706::aid-cncr28205

    authors: Vogl SE,Komisar A,Kaplan BH,Engstrom PF,Kasule OH,Stolbach L,Lerner H,Muggia F

    更新日期:1986-02-15 00:00:00

  • Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion.

    abstract:BACKGROUND:Single-agent chemotherapy produces partial responses in the range of 7-27% in patients with Stage IV nonsmall cell lung carcinoma (NSCLC). Cisplatin-based combination regimens have achieved higher response rates but with significant toxicity. Two prior studies employing 24-hour infusions of paclitaxel showed...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Tester WJ,Jin PY,Reardon DH,Cohn JB,Cohen MH

    更新日期:1997-02-15 00:00:00

  • Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors.

    abstract:BACKGROUND:This study analyzed whether proliferative activity and expression of P-glycoprotein 170 (P-170) or glutathione S-transferase-pi (GST-pi) in human non-small cell lung carcinomas (NSCLC) represent independent factors in resistance to doxorubicin or whether an association exists between these factors. METHODS:...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920815)70:4<764::aid-cncr28207

    authors: Volm M,Mattern J,Samsel B

    更新日期:1992-08-15 00:00:00

  • Determination of transforming growth factor activity in effusions from cancer patients.

    abstract::Transforming growth factors (TGF) are polypeptides that stimulate anchorage-independent growth of various nontransformed cells in vitro. Transforming growth factors have been found in tumor extracts and in the urine of cancer patients. The specific questions of our study were whether TGF activity can be detected in ma...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880501)61:9<1832::aid-cncr2820

    authors: Hanauske AR,Arteaga CL,Clark GM,Buchok J,Marshall M,Hazarika P,Pardue RL,Von Hoff DD

    更新日期:1988-05-01 00:00:00

  • Systemic giant-cell histiocytosis: report of a case and a review of the adult form of Letterer-Siwe disease.

    abstract::The multiple classifications of histiocytic disorders, and the lack of specificity in their application, have degraded the utility of such diagnostic terms as "Letterer-Siwe Disease" and "Malignant Histiocytosis". A case is presented of a systemic histiocytic proliferation with erythrophagocytosis and giant-cell forma...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(197612)38:6<2529::aid-cncr282038

    authors: Wolfson WL,Gossett T,Pagani J

    更新日期:1976-12-01 00:00:00

  • Autologous bone marrow rescue in the treatment of advanced tumors of childhood.

    abstract::High-dose multiagent chemotherapy followed by autologous marrow rescue was used in the treatment of 13 patients with Stage III or IV childhood tumors. Encouraging results are being obtained in abdominal lymphoma (1/3 complete remissions (CR); rhabdomyosarcoma (2/4 CR); and retinoblastoma (1/2 CR). In neuroblastoma, th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820201)49:3<603::aid-cncr28204

    authors: Ekert H,Ellis WM,Waters KD,Tauro GP

    更新日期:1982-02-01 00:00:00

  • Physical fitness and modifiable cardiovascular disease risk factors in survivors of childhood cancer: A report from the SURfit study.

    abstract:BACKGROUND:Childhood cancer survivors are at risk for cardiovascular disease (CVD) because of intensive cancer therapies often accompanied by an unhealthy lifestyle. This study was aimed at 1) describing modifiable CVD risk factors in survivors and 2) investigating the association between different aspects of physical ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33351

    authors: Schindera C,Zürcher SJ,Jung R,Boehringer S,Balder JW,Rueegg CS,Kriemler S,von der Weid NX

    更新日期:2021-01-06 00:00:00

  • Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.

    abstract:BACKGROUND:Immune checkpoint inhibitors (ICIs) represent an appealing treatment for patients with advanced urothelial cancer (aUC) and a poor performance status (PS). However, the benefit of ICIs for patients with a poor PS remains unknown. It was hypothesized that a poor Eastern Cooperative Oncology Group (ECOG) PS (≥...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.32645

    authors: Khaki AR,Li A,Diamantopoulos LN,Bilen MA,Santos V,Esther J,Morales-Barrera R,Devitt M,Nelson A,Hoimes CJ,Shreck E,Assi H,Gartrell BA,Sankin A,Rodriguez-Vida A,Lythgoe M,Pinato DJ,Drakaki A,Joshi M,Isaacsson Velho P

    更新日期:2020-03-15 00:00:00

  • Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.

    abstract:BACKGROUND:Carboplatin-based regimens have demonstrated activity in pediatric patients with low-grade glioma (LGG). However, carboplatin hypersensitivity reaction (Cb HSR) represents a common and limiting factor for the continuation of therapy. METHODS:The objectives of this study were to describe the prevalence, char...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.23249

    authors: Lafay-Cousin L,Sung L,Carret AS,Hukin J,Wilson B,Johnston DL,Zelcer S,Silva M,Odame I,Mpofu C,Strother D,Bouffet E

    更新日期:2008-02-15 00:00:00

  • Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

    abstract:BACKGROUND:Many studies have tried to identify prognostic factors to guide the selection of patients at high risk for metastases in penile carcinoma. The authors evaluated human papillomavirus (HPV) status with respect to clinical features, incidence of metastases, and prognosis of penile carcinoma. METHODS:Human papi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Bezerra AL,Lopes A,Santiago GH,Ribeiro KC,Latorre MR,Villa LL

    更新日期:2001-06-15 00:00:00

  • Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.

    abstract:BACKGROUND:Although flow cytometric DNA analysis has been recognized to be a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus, the biologic significance of DNA aneuploidy remains to be elucidated. METHODS:Twenty-five patients with squamous cell carcinoma of the esophagus who under...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Watanabe M,Kuwano H,Tanaka S,Toh Y,Sadanaga N,Sugimachi K

    更新日期:1999-06-01 00:00:00

  • Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.

    abstract:BACKGROUND:Aberrant expression of the facilitative glucose transporter, GLUT1, is found in a wide spectrum of epithelial malignancies. The current study describes an immunohistochemical study of GLUT1 expression in benign, hyperplastic, and malignant endometrial epithelia. METHODS:One hundred sixteen formalin fixed, p...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Wang BY,Kalir T,Sabo E,Sherman DE,Cohen C,Burstein DE

    更新日期:2000-06-15 00:00:00

  • Primary reticulum cell sarcoma of testis in a 12-year-old.

    abstract::A 12-year-old boy with primary reticulum cell sarcoma of the testis who is alive and free of tumor 32 months after orchiectomy, radiation therapy to inguinal, iliac and retroperitoneal lymph nodes and chemotherapy is reported. Seven previously documented cases of childhood primary testicular lymphoma are reviewed. The...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197602)37:2<935::aid-cncr2820370

    authors: Weitzner S,Gropp A

    更新日期:1976-02-01 00:00:00

  • Racial segregation and disparities in breast cancer care and mortality.

    abstract:BACKGROUND:Questions have existed as to whether residential segregation is a mediator of racial/ethnic disparities in breast cancer care and breast cancer mortality, or has a differential effect by race/ethnicity. METHODS:Data from the Surveillance, Epidemiology, and End Results-Medicare database on white, black, and ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23828

    authors: Haas JS,Earle CC,Orav JE,Brawarsky P,Keohane M,Neville BA,Williams DR

    更新日期:2008-10-15 00:00:00

  • Factor VIII related antigen in adenomatoid tumors: implications for histogenesis.

    abstract::The current study was undertaken to reevaluate the histogenesis of adenomatoid tumor by an immunoperoxidase method of detecting factor VIII related antigen, a tissue specific marker for vascular endothelium. Three of eight adenomatoid tumors showed diffuse cytoplasmic staining of the cells lining the lumina. When thes...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820901)50:5<932::aid-cncr28205

    authors: Bell DA,Flotte TJ

    更新日期:1982-09-01 00:00:00

  • Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy?

    abstract::Recent follow-up studies of patients with mammary carcinoma treated with breast-conserving primary radiotherapy identified a triad of pathologic features significantly associated with local treatment failure. These unfavorable characteristics of the primary tumor were: poor or undifferentiated nuclear grade; intraduct...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860401)57:7<1415::aid-cncr2820

    authors: Rosen PP,Kinne DW,Lesser M,Hellman S

    更新日期:1986-04-01 00:00:00

  • The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.

    abstract:BACKGROUND:Because patients with germ cell tumors expect an additional life span of around 50 years after successful treatment, attention is now focused on potential long term toxicity. Limited data are available on Leydig cell function in long term survivors. METHODS:The authors measured testosterone, sex hormone bin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010401)91:7<1297::aid-cncr1132

    authors: Gerl A,Mühlbayer D,Hansmann G,Mraz W,Hiddemann W

    更新日期:2001-04-01 00:00:00

  • Utilization of a human tumor cloning system to monitor for bone marrow involvement in children with non-hodgkin's lymphoma.

    abstract::The objective of this study was to evaluate the sensitivity of two methods for determining bone marrow involvement with non-Hodgkin's lymphoma. These methods were histologic review of bone marrow aspirates, and clot sections versus in vitro growth of lymphoma colonies on soft agar. Forty-two bone marrow aspirates were...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840415)53:8<1724::aid-cncr2820

    authors: Smith SD,Kisker S,Bush L,Trueworthy RC

    更新日期:1984-04-15 00:00:00

  • Medullary carcinoma of the breast. An unusual cytologic finding in cyst fluid aspirates.

    abstract::Cystic medullary carcinoma of the breast is unusual. This report describes five patients with medullary carcinoma who presented clinically with a breast cyst. Fine-needle aspiration biopsy (NAB) was performed as part of the initial physical examination and the retrieved cyst fluid was examined cytologically. Four of t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900115)65:2<277::aid-cncr28206

    authors: Howell LP,Kline TS

    更新日期:1990-01-15 00:00:00

  • Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.

    abstract:BACKGROUND:This retrospective study evaluated the benefit of using tumor necrosis factor (TNF) and melphalan administered via an isolated limb perfusion (ILP) in a series of patients with metastatic melanoma who failed initial ILP with chemotherapeutics. METHODS:Seventeen patients with extremity melanoma who underwent...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19971201)80:11<2084::aid-c

    authors: Bartlett DL,Ma G,Alexander HR,Libutti SK,Fraker DL

    更新日期:1997-12-01 00:00:00